Skip to main content
. 2022 Jul 12;10(3):E643–E651. doi: 10.9778/cmajo.20210228

Figure 2:

Figure 2:

Serology results of participants (n = 352). Participants with immunoglobulin (Ig) G antibodies against SARS-CoV-2 were considered seropositive.